What is the current Point-of-care Testing (POCT) for Chronic Disease market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the POCT market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the POCT for Chronic Disease market?

Increasing prevalence of chronic diseases and rising demand for diagnostic testing drive the market.

What are the challenges faced by the POCT for Chronic Disease market?

Regulatory frameworks and reimbursement issues pose significant challenges to market growth.

Which regions are the leaders in the POCT for Chronic Disease market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the POCT for Chronic Disease market?

Major players include Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers.

What are the future opportunities in the POCT for Chronic Disease market?

Emerging markets and technological advancements offer significant future outlook opportunities.

How does technology impact the POCT for Chronic Disease market?

Advances in technology improve test accuracy and convenience, driving market growth and future outlook.

What is the current regulatory landscape for the POCT for Chronic Disease market?

Regulations vary by region, with FDA and CE marking being key certifications for market entry.

How will the regulatory landscape impact the future of the POCT market?

Stricter regulations may increase barriers to entry, but also ensure higher quality products and patient safety.

Point-of-care Testing (POCT) for Chronic Disease Market Potential & Strategic Outlook 2033

Point-of-care Testing (POCT) for Chronic Disease by Application (Hospital, lndependent Testing Organization), by Types (Based on Immunochromatography, Based on Chemiluminescence Technology, Based on Biosensor, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Point-of-care Testing (POCT) for Chronic Disease Market Size | CAGR 10.2 Forecast 2033

Point-of-care Testing (POCT) for Chronic Disease Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Point-of-care Testing (POCT) for Chronic Disease Market Overview

The Point-of-care Testing (POCT) for Chronic Disease market refers to the diagnostic testing performed at or near the site of patient care. As the Point-of-care Testing (POCT) for Chronic Disease market size is estimated to be around $13.4 billion in 2025, the growth outlook and market forecast indicate a significant expansion of the industry. The Point-of-care Testing (POCT) for Chronic Disease market is expected to grow at a CAGR of 10.3% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of chronic diseases, technological advancements, and the rising demand for rapid diagnostic testing. The scope of the market encompasses various diagnostic testing technologies, including glucose monitoring, blood gas analysis, and molecular diagnostics, catering to the needs of healthcare providers, patients, and research institutions.

Loading chart…

Key forces shaping the Point-of-care Testing (POCT) for Chronic Disease industry include technological shifts towards portable and wearable devices, regulations promoting patient-centered care, and changing consumer behavior driven by the demand for convenient and affordable healthcare solutions. The largest region in the Point-of-care Testing (POCT) for Chronic Disease market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing healthcare expenditure and government initiatives. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; BioMerieux; Siemens Healthineers; Roche; Danaher; Sinocare Inc; Assure Tech (Hangzhou) Co.,Ltd.; Bio-Rad Laboratories; Guangzhou Wondfo Biotech Co.,Ltd.; Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Point-of-care Testing (POCT) for Chronic Disease market is experiencing significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the Point-of-care Testing (POCT) for Chronic Disease market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of chronic diseases, such as diabetes and cardiovascular disease, is driving the demand for POCT devices, thereby contributing to the growth of the Point-of-care Testing (POCT) for Chronic Disease market.

Advances in technology have led to the development of portable, user-friendly, and cost-effective POCT devices, making them more accessible to healthcare professionals and patients, which is expected to boost the growth forecast of the Point-of-care Testing (POCT) for Chronic Disease market.

Restraints2 items

Stringent regulatory requirements and the need for regulatory approvals can hinder the growth of the Point-of-care Testing (POCT) for Chronic Disease market, as companies may struggle to comply with the evolving regulatory landscape.

High development costs associated with POCT devices can limit the entry of new players in the market, thereby restricting the growth of the Point-of-care Testing (POCT) for Chronic Disease market size.

Opportunities2 items

Emerging economies present significant opportunities for the growth of the Point-of-care Testing (POCT) for Chronic Disease market, as these regions are experiencing an increase in the prevalence of chronic diseases and have a growing need for POCT devices.

The integration of artificial intelligence and machine learning in POCT devices is expected to enhance their accuracy and efficiency, thereby creating new opportunities for the growth of the Point-of-care Testing (POCT) for Chronic Disease market.

Challenges2 items

Ensuring the accuracy and reliability of POCT devices is a significant challenge, as these devices are used to make critical healthcare decisions, and any errors can have severe consequences, which can impact the growth forecast of the Point-of-care Testing (POCT) for Chronic Disease market.

The cost of POCT devices can be a significant barrier to their adoption, particularly in resource-poor settings, which can limit the growth of the Point-of-care Testing (POCT) for Chronic Disease market size.

Market Segmentation

Loading chart…

The Point-of-care Testing (POCT) for Chronic Disease segmentation by application refers to the categorization of POCT devices based on the specific chronic diseases they are used to diagnose and monitor. This segmentation is crucial in understanding the market size and growth potential of POCT devices for various chronic diseases. The application segment includes diabetes, cardiovascular diseases, respiratory diseases, and other chronic diseases. Each of these applications contributes significantly to the overall Point-of-care Testing (POCT) for Chronic Disease market size.

The types of POCT devices for chronic diseases can be further segmented into glucose monitoring devices, lipid profiling devices, blood gas and electrolyte analyzers, and infectious disease testing devices. These devices are designed to provide rapid and accurate results, enabling healthcare professionals to make informed decisions about patient care. The types of POCT devices are a critical component of the Point-of-care Testing (POCT) for Chronic Disease market taxonomy, as they determine the scope and potential of the market.

Point-of-care Testing (POCT) for Chronic Disease Segmentation Breakdown8 items

Application

Hospital

lndependent Testing Organization

Types

Based on Immunochromatography

Based on Chemiluminescence Technology

Based on Biosensor

Others

Regional Insights

Loading chart…

The Point-of-care Testing (POCT) for Chronic Disease market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of POCT devices, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - ecosystem maturity, high demographics of chronic disease patients, and advanced infrastructure; Europe - policies supporting POCT adoption, rising chronic disease prevalence, and established healthcare systems; Asia Pacific - large underserved population, growing healthcare expenditure, and increasing awareness of POCT benefits; Latin America - expanding middle class, increasing healthcare access, and rising demand for POCT devices; Middle East & Africa - growing investment in healthcare, increasing prevalence of chronic diseases, and improving infrastructure.

The regional forecast indicates a significant growth opportunity for POCT devices in emerging markets, driven by increasing demand for healthcare services and rising awareness of chronic diseases. As the Point-of-care Testing (POCT) for Chronic Disease market continues to evolve, understanding the regional dynamics and key drivers will be crucial for stakeholders to capitalize on the growth opportunities.

Competitive Landscape

The Point-of-care Testing (POCT) for Chronic Disease market is moderately consolidated, with a mix of global players and local/regional companies. The market is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Point-of-care Testing (POCT) for Chronic Disease competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service model, and channel strength.

Companies in this market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are examples of this:

Abbott: regional expansion

BioMerieux: innovation pipeline

Siemens Healthineers: premium pricing

Roche: OEM tie-ups

Danaher: vertical integration

Sinocare Inc: local manufacturing

Key Point-of-care Testing (POCT) for Chronic Disease Companies10 items

Abbott

BioMerieux

Siemens Healthineers

Roche

Danaher

Sinocare Inc

Assure Tech (Hangzhou) Co.,Ltd.

Bio-Rad Laboratories

Guangzhou Wondfo Biotech Co.,Ltd.

Wuhan Easy Diagnosis Biomedicine Co.,ltd.

Market Ecosystem

The Point-of-care Testing (POCT) for Chronic Disease ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers, midstream integrators and channels, to downstream end users. Value is created and captured through the development, manufacturing, and distribution of POCT devices, as well as the provision of related services and support. This ecosystem can be understood through a value chain analysis, which reveals the interconnected roles and relationships between various participants.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and produce POCT devices

Technology providers — develop underlying technologies

System integrators / EPCs — integrate POCT devices into healthcare systems

Distributors / channel partners — deliver POCT devices to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce regulatory standards

The flow of value through the Point-of-care Testing (POCT) for Chronic Disease ecosystem is influenced by various control points, including regulatory approvals, reimbursement policies, and partnerships between stakeholders. Dependency risks, such as input constraints and standards compliance, can impact the availability and adoption of POCT devices. Furthermore, switching costs, interoperability requirements, and regional differences in healthcare systems and regulations can also affect the ecosystem's dynamics, highlighting the need for a nuanced understanding of these factors to navigate the POCT for Chronic Disease ecosystem effectively.

Recent Industry Insights

The Point-of-care Testing (POCT) for Chronic Disease industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between major pharmaceutical companies and POCT device manufacturers, have driven innovation in the field. Notable mergers and acquisitions have also taken place, leading to consolidation and expansion of product portfolios. Furthermore, several companies have launched new products and technologies, enhancing the diagnostic capabilities of POCT devices.

Additionally, regulatory changes have paved the way for increased adoption of POCT devices, with a shift in consumer trends towards personalized medicine and remote patient monitoring. The industry has also seen significant funding rounds and expansions, with investors backing companies that develop innovative POCT solutions. These developments are expected to shape the future of the POCT for Chronic Disease industry, driving growth and improving patient outcomes.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Point-of-care Testing (POCT) for Chronic Disease market outlook is highly attractive due to the increasing prevalence of chronic diseases and the growing demand for decentralized healthcare solutions. The competitive intensity in this market is moderate, with key players investing heavily in research and development to improve existing technologies and expand their product portfolios.

The long-term outlook for this market is promising, driven by advancements in innovation landscape and the rising adoption of POCT devices in demand–supply balance. However, key risk factors such as regulatory challenges and reimbursement issues may impact market growth. Overall, our analysis suggests that the POCT for Chronic Disease market is poised for significant expansion, offering opportunities for stakeholders to capitalize on emerging trends and technologies.

12 items

1. Executive Summary

2. Point-of-care Testing (POCT) for Chronic Disease Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Point-of-care Testing (POCT) for Chronic Disease Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Point-of-care Testing (POCT) for Chronic Disease Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Point-of-care Testing (POCT) for Chronic Disease Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Point-of-care Testing (POCT) for Chronic Disease Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Point-of-care Testing (POCT) for Chronic Disease Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Point-of-care Testing (POCT) for Chronic Disease Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Point-of-care Testing (POCT) for Chronic Disease Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Point-of-care Testing (POCT) for Chronic Disease Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Point-of-care Testing (POCT) for Chronic Disease Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Point-of-care Testing (POCT) for Chronic Disease Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Point-of-care Testing (POCT) for Chronic Disease Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Point-of-care Testing (POCT) for Chronic Disease Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Point-of-care Testing (POCT) for Chronic Disease Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Point-of-care Testing (POCT) for Chronic Disease Market Competition by Key Manufacturers

9.1. Global Point-of-care Testing (POCT) for Chronic Disease Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Point-of-care Testing (POCT) for Chronic Disease: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BioMerieux

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Siemens Healthineers

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Roche

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Danaher

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sinocare Inc

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Assure Tech (Hangzhou) Co.,Ltd.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Bio-Rad Laboratories

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Guangzhou Wondfo Biotech Co.,Ltd.

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Wuhan Easy Diagnosis Biomedicine Co.,ltd.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Point-of-care Testing (POCT) for Chronic Disease Market

Figure 4: Global Point-of-care Testing (POCT) for Chronic Disease Market: Drivers

Figure 5: Global Point-of-care Testing (POCT) for Chronic Disease Market: Challenges

Figure 6: Global Point-of-care Testing (POCT) for Chronic Disease Market: Trends

Figure 7: Global Point-of-care Testing (POCT) for Chronic Disease Market: Opportunity

Figure 8: Global Point-of-care Testing (POCT) for Chronic Disease Market: Restraint

Figure 9: Global Point-of-care Testing (POCT) for Chronic Disease Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Point-of-care Testing (POCT) for Chronic Disease Market Value (USD Million) By Region

Figure 19: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Point-of-care Testing (POCT) for Chronic Disease Market Value (USD Million) By Region

Figure 27: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By: Regions (2032)

Figure 28: Global Point-of-care Testing (POCT) for Chronic Disease Market Volume (K) By Region

Figure 29: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Point-of-care Testing (POCT) for Chronic Disease Market Value (USD Million) By Region

Figure 37: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By: Regions (2032)

Figure 38: Global Point-of-care Testing (POCT) for Chronic Disease Market Volume (K) By Region

Figure 39: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Point-of-care Testing (POCT) for Chronic Disease Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Point-of-care Testing (POCT) for Chronic Disease Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Point-of-care Testing (POCT) for Chronic Disease Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Point-of-care Testing (POCT) for Chronic Disease Market Value (USD Million) By Region

Table 14: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Point-of-care Testing (POCT) for Chronic Disease Market Volume (K) By Region

Table 31: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Point-of-care Testing (POCT) for Chronic Disease Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Point-of-care Testing (POCT) for Chronic Disease Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Point-of-care Testing (POCT) for Chronic Disease Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Basic Information And Sales Area

Table 52: Abbott. Products Portfolio

Table 53: BioMerieux Basic Information And Sales Area

Table 54: BioMerieux. Products Portfolio

Table 55: Siemens Healthineers Basic Information And Sales Area

Table 56: Siemens Healthineers. Products Portfolio

Table 57: Roche Basic Information And Sales Area

Table 58: Roche. Products Portfolio

Table 59: Danaher Basic Information And Sales Area

Table 60: Danaher. Products Portfolio

Table 61: Sinocare Inc Basic Information And Sales Area

Table 62: Sinocare Inc. Products Portfolio

Table 63: Assure Tech (Hangzhou) Co.,Ltd. Basic Information And Sales Area

Table 64: Assure Tech (Hangzhou) Co.,Ltd.. Products Portfolio

Table 65: Bio-Rad Laboratories Basic Information And Sales Area

Table 66: Bio-Rad Laboratories. Products Portfolio

Table 67: Guangzhou Wondfo Biotech Co.,Ltd. Basic Information And Sales Area

Table 68: Guangzhou Wondfo Biotech Co.,Ltd.. Products Portfolio

Table 69: Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information And Sales Area

Table 70: Wuhan Easy Diagnosis Biomedicine Co.,ltd.. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Point-of-care Testing (POCT) for Chronic Disease Market Value (USD Million) By Region

Table 80: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Point-of-care Testing (POCT) for Chronic Disease Market Volume (K) By Region

Table 97: Global Point-of-care Testing (POCT) for Chronic Disease Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Point-of-care Testing (POCT) for Chronic Disease Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; BioMerieux; Siemens Healthineers; Roche; Danaher; Sinocare Inc; Assure Tech (Hangzhou) Co.,Ltd.; Bio-Rad Laboratories; Guangzhou Wondfo Biotech Co.,Ltd.; Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options